HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
IPO Year:
Exchange: NYSE
Website: hexocorp.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/4/2022 | $1.00 → $1.25 | Hold → Speculative Buy | Canaccord Genuity |
| 3/4/2022 | Hold → Speculative Buy | Canaccord Genuity | |
| 3/4/2022 | $1.20 → $0.90 | Neutral | Cantor Fitzgerald |
| 1/27/2022 | $1.07 → $0.53 | Underperform → Hold | Jefferies |
| 12/15/2021 | $2.00 → $0.80 | Neutral → Underperformer | CIBC |
| 12/15/2021 | Neutral → Sector Underperform | CIBC | |
| 12/15/2021 | $2.10 → $1.20 | Neutral | Cantor Fitzgerald |
| 10/29/2021 | $2.29 → $2.10 | Neutral | Cantor Fitzgerald |
| 10/28/2021 | $3.45 → $2.29 | Neutral | Cantor Fitzgerald |
| 8/31/2021 | $3.40 → $3.45 | Neutral | Cantor Fitzgerald |
15-12G - HEXO Corp. (0001690947) (Filer)
25-NSE - HEXO Corp. (0001690947) (Subject)
F-10POS - HEXO Corp. (0001690947) (Filer)
F-10POS - HEXO Corp. (0001690947) (Filer)
6-K - HEXO Corp. (0001690947) (Filer)
6-K - HEXO Corp. (0001690947) (Filer)
6-K - HEXO Corp. (0001690947) (Filer)
6-K - HEXO Corp. (0001690947) (Filer)
6-K - HEXO Corp. (0001690947) (Filer)
6-K - HEXO Corp. (0001690947) (Filer)
Canaccord Genuity upgraded HEXO from Hold to Speculative Buy and set a new price target of $1.25 from $1.00 previously
Canaccord Genuity upgraded HEXO from Hold to Speculative Buy
Cantor Fitzgerald reiterated coverage of HEXO with a rating of Neutral and set a new price target of $0.90 from $1.20 previously
Jefferies upgraded HEXO from Underperform to Hold and set a new price target of $0.53 from $1.07 previously
CIBC downgraded HEXO from Neutral to Underperformer and set a new price target of $0.80 from $2.00 previously
CIBC downgraded HEXO from Neutral to Sector Underperform
Cantor Fitzgerald reiterated coverage of HEXO with a rating of Neutral and set a new price target of $1.20 from $2.10 previously
Cantor Fitzgerald reiterated coverage of HEXO with a rating of Neutral and set a new price target of $2.10 from $2.29 previously
Cantor Fitzgerald reiterated coverage of HEXO with a rating of Neutral and set a new price target of $2.29 from $3.45 previously
Cantor Fitzgerald reiterated coverage of HEXO with a rating of Neutral and set a new price target of $3.45 from $3.40 previously
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today the closing of the second of two tranches of the non-brokered private placement of Series 1 Preferred Shares (the "Private Placement") previously announced on June 1, 2023 and the subsequent completion of the transactions contemplated by the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Arrangement") involving the Company and Tilray Brands, Inc. ("Tilray"). "On behalf of HEXO's board and management team, I'd like to extend our deepest thanks to the entire HEXO team for their continued commitment to our business and customers," said Charlie Bow
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today that the Ontario Superior Court of Justice (Commercial List) (the "Court") has granted the final order (the "Final Order") in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the "Arrangement"), pursuant to which Tilray Brands, Inc. ("Tilray") will acquire all of the issued and outstanding common shares (the "Common Shares") and non-voting Series 1 Preferred Shares of the Company. Holders of Common Shares of the Company (the "Common Shareholders") will receive 0.4352 of a share of Tilray common stock (the "Tilray Shares") for each w
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, today reported its financial results for the third quarter of the 2023 fiscal year ("Q3'23"). All currency amounts are stated in Canadian dollars unless otherwise noted. "In the third quarter, we entered into a definitive arrangement agreement whereby Tilray will acquire all outstanding shares of HEXO," said Charlie Bowman, President and Chief Executive Officer of HEXO. "We continue to expect the transaction will be completed by June 30, 2023." "HEXO recorded $21.6 million in net revenues in the third quarter, representing an 11% decline from the second quarter," noted Jul
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today that at the special meeting of its common shareholders held earlier today, its common shareholders approved the previously announced arrangement agreement, as amended, with Tilray Brands, Inc. ("Tilray"), whereby Tilray will acquire, by way of court-approved plan of arrangement (the "Arrangement"), all of the issued and outstanding common shares of the Company (the "Common Shares"). Common shareholders will receive 0.4352 of a share of Tilray common stock (the "Tilray Shares") for each whole Common Share held, while holders of the recently issued non-voting Series 1 Preferred Shares will receive a fraction or a num
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021 HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio-only conference call on Thursday, June 15, 2023, at 10 a.m. EDT, to review its financial results for the third fiscal quarter, ended April 30, 2023. The results will be released after market close on Wednesday, June 14, 2023. Following the prepared remarks, there will be a question-and-answer session. Ch
First Tranche Raised Gross Proceeds of US$11.5 Million; Second Tranche Proceeds of US$13.5 Million Deposited into Escrow HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today that it has closed the first of two tranches of a non-brokered private placement (the "Private Placement") consisting of the issuance of newly created Series 1 Preferred Shares (the "Preferred Shares") to a single institutional investor. The first tranche consisted of the issuance of 11,500,000 Preferred Shares at an issue price of US$1.00 per Preferred Share for gross proceeds to the Company of US$11,500,000. The Preferred Shares are non-voting and are entitled to a preference over the common
ISS Concludes the Arrangement Makes Strategic Sense No Viable Alternatives for HEXO Other Than the Arrangement with Tilray Shareholders Who Have Questions or Need Assistance Voting Should Contact Kingsdale Advisors, by phone at 1-866-581-1489 (North America Toll Free) or 416-623-2516 (Outside North America), or by email at [email protected] For more information, please visit www.HEXOVOTE.com HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") is pleased to announce that Institutional Shareholder Services Inc. ("ISS"), a leading independent proxy advisory firm, has issued a report recommending that HEXO Shareholders vote FOR the arrangement agreement (the
Tilray Arrangement Determined to be Fair to Shareholders and in the Best Interests of the Company No Viable Alternatives for HEXO Other Than the Arrangement with Tilray Shareholders Encouraged to Vote In Advance of the Special Meeting on June 14, 2023 Shareholders Who Have Questions or Need Assistance Voting Should Contact Kingsdale Advisors, by phone at 1-866-581-1489 (North America Toll Free) or 416-623-2516 (Outside North America), or by email at [email protected] For more information, please visit www.HEXOVOTE.com HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") announced today the mailing of the management information circular (the "Circular") for th
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") is pleased to announce that in connection with its previously announced arrangement agreement with Tilray Brands, Inc. ("Tilray") for a transaction whereby Tilray has agreed to acquire all of the issued and outstanding common shares of the Company by way of court-approved plan of arrangement (the "Arrangement"), HEXO has obtained an interim order from the Ontario Superior Court of Justice (Commercial List) providing for, among other things, the holding of a special meeting (the "Special Meeting") of the holders of common shares of HEXO (the "Shareholders") to approve the Arrangement under the Business Corporations Act (Ontario). T
HUNTINGDON, Quebec, May 02, 2023 (GLOBE NEWSWIRE) -- ROSE LifeScience Inc. ("ROSE"), a Québec-based cannabis producer, distributor, and marketer, today announced that it will add HEXO Corp.'s ("HEXO") Québec portfolio to ROSE's industry leading commercialization and distribution services business. Headquartered in Gatineau, Québec, HEXO delivers premium cannabis experiences that inspire customer loyalty, from recreational to therapeutic products. HEXO's products balance THC with CBD, terpene levels and flavonoids, to create high-quality, clean, consistent customer favourites. HEXO's state-of-the-art facilities in Masson-Angers, Québec are purpose-built and engineered to provide exceptiona
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO"), a leading producer of high-quality cannabis products, today announced that at the annual general meeting of shareholders held on January 31, 2023 (the "Meeting"), each of the eight director nominees was elected as a director of HEXO. Detailed results of the vote are set out below. Nominee Votes For Votes Withheld Total Votes Cast Percentage of Votes For Percentage of Votes Withheld Mark Attanasio 2,063,211 434,874 2,498,058 82.592% 17.408% Vincent Chiara 1,983,425 514,662 2,498,087 79.398% 20.602% Denise Faltischek 2,072,889 425,198 2,498,087 82.979% 17.021% Hélène
Scott Cooper Steps Down; Board of Directors Acknowledge Cooper in Stabilizing the Company Bowman and Ivancsits to Lead HEXO's Continued Transformation and Growth GATINEAU, Quebec, April 29, 2022 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX:HEXO, NASDAQ:HEXO) today announced that Charlie Bowman has been appointed the Company's acting President and Chief Executive Officer, effective today. Mr. Bowman will move into a permanent role upon the successful completion of Health Canada's security clearance process for key personnel, which has been initiated. Concurrently, Scott Cooper is stepping down from his role as HEXO's President and Chief Executive Officer. "I am honoured t
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 11, 2021 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. GATINEAU, Quebec, Jan. 05, 2022 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO", or the "Company") (TSX:HEXO, NASDAQ:HEXO), today announced the appointment of William Todd Montour to the Company's Board of Directors following the resignation of Jason Ewart, effective immediately. "I am pleased to welcome Will to the Board, and I am confident that his experience in cannabis operations and commercialization will be invaluable to the Company as we enter our next stage of
GATINEAU, Quebec, Dec. 14, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (TSX:HEXO, NASDAQ:HEXO), a leading producer of high-quality cannabis products, today announced the appointment of John K. Bell as Chair of the Board of Directors, effective December 14, 2021. "A key priority for the Company is to enhance its corporate governance and John brings a tremendous amount of experience to this role," said Scott Cooper, President and CEO of HEXO. "John's strong financial background and experience in the cannabis sector make him ideally suited as we move forward with our new plan to solidify our position as Canada's leading cannabis company." "HEXO has a strong foundation with unique capabilities and as
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 11, 2021 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021. OTTAWA, Nov. 19, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO", or the "Company") (TSX:HEXO, NASDAQ:HEXO), today announced that Sebastien St-Louis has resigned from HEXO's Board of Directors. The Company also announced that it has appointed President and CEO, Scott Cooper, as a Director to replace Sebastien St-Louis, effective yesterday. "I would like to take this opportunity to thank Sebastien for over eight years of service on HEXO's Board of Directors. Throug
OTTAWA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX:HEXO, NASDAQ:HEXO) is pleased to announce that it has appointed Guillaume Jouët as Chief People & Culture Officer, effective September 8, 2021. "We are looking forward to welcoming Guillaume to the team as we continue to expand rapidly in Canada, into the U.S. and globally," said HEXO CEO and co-founder Sebastien St-Louis. "At HEXO, we believe that people are one of our most valuable assets. As Chief People & Culture Officer, Guillaume will be a key member of our executive team as we continue to build out an intentional culture that is aligned with our corporate strategy." Guillaume brings more than 20 yea
OTTAWA, Aug. 16, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX:HEXO, NYSE:HEXO) is pleased to announce that it is expanding its global leadership team with the appointment of Valerie Malone as Chief Commercial Officer, effective September 6, 2021. "We are thrilled to welcome Valerie to HEXO," said HEXO CEO and co-founder Sebastien St-Louis. "Valerie will support HEXO's future growth as we accelerate on the path towards becoming a top three global cannabis products company and continue to generate value for our shareholders. We look forward to adding her diverse experiences and perspectives to our executive team, as we continue to drive towards positive EPS." Valerie b
OTTAWA, Feb. 08, 2021 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) announced today that it has appointed Charles Bowman as General Manager of its US operations, effective immediately. “Charlie's extensive experience in commercial growth and operations will be instrumental as we continue to expand our footprint in the US. We are excited to bring such established leadership to the team as we ramp up to support the growth initiatives of Truss CBD USA, our joint venture with Molson Coors, and for potential non-beverage CPG partners with whom we are in ongoing discussions,” said HEXO CEO and co-founder Sebastien St-Louis. Bowman is based in the US and wil
OTTAWA, Jan. 14, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is pleased to announce the appointment of Rose Marie Gage to its Board of Directors. Following the appointment of Ms. Gage, the Board will comprise of seven directors. "We are pleased to welcome Rose Marie Gage to the HEXO Board," said Dr. Michael Munzar, Chair of the Board of Directors of HEXO. “Rose’s extensive experience with large multi-national companies, strategic execution and operational effectiveness will be invaluable as we continue to aggressively push to become EPS positive, increase market share across Canada and expand operations in the United States." Ms. Gage has ov
SC 13G/A - HEXO Corp. (0001690947) (Subject)
SC 13G - HEXO Corp. (0001690947) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
SC 13G/A - HEXO Corp. (0001690947) (Subject)
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021 HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio-only conference call on Thursday, June 15, 2023, at 10 a.m. EDT, to review its financial results for the third fiscal quarter, ended April 30, 2023. The results will be released after market close on Wednesday, June 14, 2023. Following the prepared remarks, there will be a question-and-answer session. Ch
Delivered $145.6 Million in Net Revenue and 16th Consecutive Quarter of Positive Adjusted EBITDA Maintained #1 Cannabis Market Share Position in Canada, the Largest Federally Legal Cannabis Market in the World; With HEXO Transaction, Poised to Substantially Increase Canadian Revenue Medical Cannabis Leader in Europe Achieved Key Efficiency Milestones on Accelerated Path to Positive Cash Flow, Company Reiterates Cash Flow Guidance LEAMINGTON, Ontario and NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and empowering the worldwide commun
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended and restated on May 25, 2021 HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company"), a leading producer of high-quality cannabis products, announced today that it will hold an audio only conference call on March 17, 2023, at 10 a.m. EDT, to review its financial results for the second fiscal quarter, ended January 31, 2023. The results will be released after market close on Thursday, March 16, 2023. Following the prepared remarks, there will be a question-and-answer session. Charlie Bo
Profitable Quarter Includes Net Income of $52.5 Million and Adjusted EBITDA of $10.1 Million; 12th Consecutive Quarter of Positive Adjusted EBITDANet Revenue Increased 23% to $152 Million; Gross Profit Increased 31% to $39.8 Million from the Prior Year QuarterMedical Market Share Leader in Europe and #1 Leadership Position in Germany with Revenue Growth of Over 4,000%Maintained #1 Leading Marketing Share in CanadaAchieved $76 Million in Cost Synergies to Date; On-Track to Exceed Original Plan of $80 Million Ahead of Schedule and to Generate Additional $20 Million of Synergies in Fiscal 2023 LEAMINGTON, Ontario and NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray"
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dates May 11, 2021, to its short form base shelf prospectus dated May 7, 2021, and amended and restated on May 25, 2021. Senior Secured Convertible Note expected to be restructured via proposed strategic alliance with Tilray, providing the Company with financial and operating flexibility and up to $50 million of combined cost synergies, while preserving value for HEXO shareholders.New Management revises forecasts, market demand, production capacity, and opportunities for efficiencies and recognizes a $616 million in impairment losses; Executing multiple initiatives to optimiz
Proposed restructuring of Notes eliminates monthly redemption feature, amends financial covenants, extends maturity and releases US$80M in restricted cash to fund operations and strategic initiatives Both companies expected to realize commercial benefits with production efficiencies and support services of up to C$50M within 24 months to be shared equally between HEXO and Tilray Brands KAOS Capital and partners to provide additional C$180M three-year equity backstop commitment to maintain newly robust balance sheet Joint conference call to discuss announcement at 8:30 a.m. ET today GATINEAU, Quebec, March 03, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX:HEXO
GATINEAU, Quebec, Dec. 16, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX:HEXO, NASDAQ:HEXO) today announced that its fiscal 2021 annual meeting of shareholders will be held on March 8, 2022 and that its board of directors has fixed the close of business on February 4, 2022 as the record date for determining which shareholders will be entitled to receive notice of and voting at the meeting. HEXO further announces that it has received an extension from the Toronto Stock Exchange (the "TSX") permitting it to hold the upcoming annual meeting of shareholders after January 31, 2022, being later than six months after the end of its last financial year. As indicated in its requ
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dates May 11, 2021, to its short form base shelf prospectus dated May 7, 2021, and amended and restated on May 25, 2021. All amounts are expressed in Canadian dollars unless otherwise noted. HEXO reports $50.2 million in total net revenue for Q1'22, an increase of 29% compared to the fiscal quarter ended July 31, 2021 (Q4'21)Maintains #1 Market Share position in Canada1Announces new strategic plan, "The Path Forward" to strengthen its balance sheet and accelerate its transformation to become a cash flow positive company within the next four quarters. ____________1 Based on Hea
Total net sales growth of 71% quarter-over-quarter and 43% from Q4'20, marking HEXO's best quarter of sales to date.Total Q4'21 net revenue increased to $38.7 million from $22.6 million in Q3'21Total net revenue for FY21 grew 53% to $123.5 million from $80.6 million in FY20.Maintained leading market share position relative to peers as market continues to diversify.Completed the acquisition of Zenabis Global Inc. ("Zenabis") OTTAWA, Oct. 29, 2021 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) ("HEXO" or the "Company") today reported its financial results for the fourth quarter ("Q4'21") and fiscal year ended July 31, 2021 ("F'21"). All amounts are expressed in Canadian d
OTTAWA, Aug. 13, 2021 (GLOBE NEWSWIRE) -- HEXO Corp ("HEXO" or the "Company") (TSX:HEXO, NYSE:HEXO) announced today it has applied to transfer its U.S. stock exchange listing from the New York Stock Exchange to the Nasdaq. While this transfer remains subject to the approval of the Nasdaq, the Company expects the transfer to occur effective August 23, 2021 after market close. Common shares of HEXO are expected to begin trading as a Nasdaq-listed security on August 24, 2021, with the shares continuing to trade under the symbol "HEXO". "Transferring our U.S. listing to Nasdaq allows us to generate shareholder value through greater cost savings on our path towards profitability, while joining
Benzinga recently reviewed the balance sheet and cash flow trends of Canadian LPs (licensed producers). Zuanic & Associates presents crucial factual key findings: Year-to-date (YTD) the Canadian cannabis market has shown steady market growth, reported at +12%, with second-quarter (Q2) of 2023 showing a year-on-year (YoY) growth of +10%. The growth rate is good in the context of Canada's existing legal provinces, but it underperforms the U.S. market, which experienced a YoY growth rate of 9% during the same period. Canada's per capita metrics fall short of those in the U.S. Recreational consumption in Canada is around US$100 per person — much lower than even the less matured U.S. state
In an exclusive preview from Zuanic & Associates' recent cannabis equity research report, Benzinga reveals four key predictions for the next 18 months. The SAFE Banking bill is expected to pass in the fall of 2024. Key Senate players will aim for a "midpoint" compromise on add-ons and Section 10. Senate passage is likely to put pressure on the House Speaker, given that half of his caucus is in favor. The Biden Administration is expected to reschedule cannabis before the November 2024 election, possibly as Schedule II or III. That could have significant implications, including the elimination of the Section 280E tax code provision for medical cannabis. It would also require a regulatory f
https://www.marijuanamoment.net/north-carolina-senate-approves-medical-marijuana-regulatory-appointment-as-house-leader-says-heavy-handed-tactics-not-helping-legalizations-fate/ A Republican North Carolina senator is making it clear that he intends to see his medical marijuana legalization bill pass this session despite some obstinance among GOP leadership in the House—and he’s even gone so far as to include medical cannabis regulatory appointments for the yet-to-be-enacted program in a new measure that passed the Senate last week. But Sen. Bill Rabon’s (R) recent acts of defiance—including attaching an amendment to an unrelated House bill that makes its effective date contingent on his me
https://www.marijuanamoment.net/major-marijuana-industry-players-launch-super-pac-to-advance-cannabis-reform-as-2024-election-heats-up/ A coalition of marijuana businesses and advocacy groups has launched a new super PAC that will work to “raise the profile of cannabis as a national issue in the 2024 election and beyond.” And part of the strategy will involve finding industry partners to ask their customers to make “round-up” donations at the point of sale when shopping at dispensaries. The U.S. Cannabis Council (USCC) announced on Wednesday that it and its member businesses have formed the “Legalize America” super PAC, which unlike traditional political action committees can accept contri
https://www.marijuanamoment.net/schumer-touts-marijuana-banking-bill-as-bipartisan-priority-and-republican-sponsor-is-optimistic-as-long-as-measure-isnt-expanded/
Tilray (NASDAQ:TLRY) is making bold moves to secure a profitable future, and its latest acquisition of HEXO Corp. (NASDAQ:HEXO) has solidified its position as Canada's top cannabis company with a 44% market share boost, expanding its market share by 467 basis points. Despite a challenging market, the strategic combination of Tilray and HEXO is expected to drive revenue growth and create significant opportunities for increased margins and earnings, with projected annualized cost savings of over $27 million, in addition to Tilray's existing annualized cash cost savings of $122 million from the Tilray-Aphria transaction. See Also: Tilray CFO Engages Shareholders On Reddit, Addresses Concerns
HEXO has submitted a voluntary delisting application to the Toronto Stock Exchange and the Nasdaq Stock Market and, as a result of the Arrangement, the Company expects its Common Shares to be delisted from the TSX and the Nasdaq shortly.
https://www.marijuanamoment.net/schumer-is-confident-marijuana-banking-bill-will-pass-this-session-according-to-cannabis-entrepreneur-who-spoke-to-majority-leader/ Senate Majority Leader Chuck Schumer (D-NY) is “confident” Congress will be able to pass a bipartisan marijuana banking bill this session—and other Democratic senators also echoed that point, according to a cannabis industry entrepreneur who spoke with the lawmakers recently. After speaking at an event focused on higher education last week, Schumer was approached by the CEO of the Colorado-based cannabis company Simply Pure, Wanda James, who became the first Black woman in the country to own a licensed marijuana dispensary in 20
HEXO Corp. (TSX:HEXO, NASDAQ:HEXO) (“HEXO” or the “Company”) announced today that the Ontario Superior Court of Justice (Commercial List) (the “Court”) has granted the final order (the “Final Order”) in connection with the previously announced statutory plan of arrangement under section 182 of the Business Corporations Act (Ontario) (the “Arrangement”), pursuant to which Tilray Brands, Inc. (“Tilray”) will acquire all of the issued and outstanding common shares (the “Common Shares”) and non-voting Series 1 Preferred Shares of the Company. Holders of Common Shares of the Company (the “Common Shareholders”) will receive 0.4352 of a share of Tilray common stock (the “Tilray Shares”) for each wh
Canaccord Genuity analyst Matt Bottomley maintains HEXO (NASDAQ:HEXO) with a Hold and lowers the price target from C$1.5 to C$1.